Technical Analysis for CVM - Cel-Sci Corporation

Grade Last Price % Change Price Change
grade B 4.74 3.27% 0.15
CVM closed up 3.27 percent on Friday, May 24, 2019, on 81 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Down Down
See historical CVM trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Calm After Storm Range Contraction 3.27%
NR7 Range Contraction 3.27%
NR7-2 Range Contraction 3.27%
Lower Bollinger Band Walk Weakness 3.27%
Wide Bands Range Expansion 3.27%
Down 3 Days in a Row Weakness 3.27%
Down 4 Days in a Row Weakness 3.27%

Older signals for CVM ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

CEL-SCI Corporation engages in the research and development of drugs and vaccines. The company's principal product, Multikine, is under Phase III clinical trial for the treatment of head and neck cancer. The Multikine is an immunotherapeutic agent consisting of a mixture of cytokines that produce an anti-tumor immune response. It also develops Ligand Epitope Antigen Presentation System (LEAPs), a heteroconjugate technology that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune, allergies, transplantation rejection, and cancer. The company, through its LEAPS technology, develops a peptide treatment for H1N1 hospitalized patients; and CEL-2000, a rheumatoid arthritis vaccine. CEL-SCI Corporation was founded in 1983 and is based in Vienna, Virginia.
Medicine Cancer Medical Specialties Immunology Immunotherapy Immune System Rheumatoid Arthritis Vaccination Transplantation Autoimmunity Vaccine Head And Neck Cancer Allergies Treatment Of Head And Neck Cancer
Is CVM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 8.47
52 Week Low 0.82
Average Volume 1,005,799
200-Day Moving Average 3.5585
50-Day Moving Average 5.4524
20-Day Moving Average 6.475
10-Day Moving Average 5.831
Average True Range 0.6305
ADX 40.31
+DI 17.1646
-DI 35.1346
Chandelier Exit (Long, 3 ATRs ) 6.578500000000001
Chandelier Exit (Short, 3 ATRs ) 6.4015
Upper Bollinger Band 8.6971
Lower Bollinger Band 4.2529
Percent B (%b) 0.11
BandWidth 68.636293
MACD Line -0.2433
MACD Signal Line 0.1498
MACD Histogram -0.3932
Fundamentals Value
Market Cap 44.24 Million
Num Shares 9.33 Million
EPS -1.54
Price-to-Earnings (P/E) Ratio -3.08
Price-to-Sales 102.40
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.46
Resistance 3 (R3) 5.48 5.27 5.34
Resistance 2 (R2) 5.27 5.08 5.26 5.30
Resistance 1 (R1) 5.00 4.97 5.14 4.98 5.26
Pivot Point 4.79 4.79 4.85 4.78 4.79
Support 1 (S1) 4.52 4.60 4.66 4.50 4.22
Support 2 (S2) 4.31 4.49 4.30 4.18
Support 3 (S3) 4.04 4.31 4.14
Support 4 (S4) 4.02